Member Info for Ctw2014

In my opinion it is pretty clear that Sustainable (or at least an institutional holder) is still selling from the large sell trades reported regularly, including today. I doubt many retail holders would have such large lumps to sell.

Why can’t LSE get anything right? SP shown is clearly not the mid of the bid/ask.

Hi Technik - cheers good to see you are still here and posting

Cheers Bigal. Dave, not really. There were a few detractors but even they were civil and rational. It’s a good question isn’t it. If your not invested, why bother? De ramping to try to get a better price? Just bitter? Who knows? All I know is that if I sell up I say so and then make a point not to post again. I don’t feel it’s right to **** on other people’s investments, if you see what I mean.

As I said in an earlier post, I have just bought back in because, in my judgment (which may be right or wrong) it’s a good time to do so, after the SP has been bashed (along with plenty of others) following the Pfizer announcement, bringing the SP well below the last placing price. I held GDR for years and regularly spoke about its potential, arguing against the cynics for ages, while the SP dropped as low as 9p. And then what happened? A pandemic came along, GDR jumped on the Covid testing bandwagon and we went through the roof! I sold (a bit too early but still with a decent profit) in anticipation of a placing (which did come) and so have been watching and waiting ever since. My point is, some people seem to take a view about a company based on how well, or how badly, they have done with it, which often is just a matter of timing, even luck, rather than anything fundamentally good or bad about the company. Worse, people who have done badly seem to lash out at others who’s view doesn’t accord with their own. It’s a pity. This board used to be far less busy, but at least it was civil and those that did post could do so, even if holding different views, without hurling insults around like school kids. Maybe we could get back to that????

Bodes well for tomorrow. GLA

Yeah Cropex, Zero/Polaris, and several others have loads of potential and are also likely to be game changers, but any sniff of Starcom kit being involved in the Worldwide distribution challenge of getting Covid vaccines rolled out would send the SP through the roof imo.

This whole vaccine transport/monitoring issue could well be the making of Star. Well done those that have been flagging the issue for months now. You know who you are.

Cheers Grimshady

That’s what I was thinking. I bought back in here after the recent drop because we are now well below the placing price and well placed to move up again on any news. I get the feeling that several on here got caught out and are now bitter, which is understandable but, for those that are still invested, it hardly helps to trash their own investment. For any that are not holding, you have to question why they would bother posting, unless of course they want back in and are trying to get a cheaper price.

.... that the Interims showed revenues up by nearly 300% to just over £1m for the six months and we are in target for £4m for the full year. None of that had anything to do with the breath test. If that’s a success, great, but it’s a bonus. This was a good company before Covid and will be a better a company post Covid. People are also blaming GB for a drop in share price which was simply a market over reaction to the Pfizer announcement, which affected all so called ‘Covid’ stocks, so nothing to do with the performance of the company or GB. I took advantage of the drop and topped up. I am confident that will pay off in due course and am not in a hurry. My advice? Chill and relax. Otherwise, no advice given and please DYOR!

At first I thought the SP was another LSE glitch but, having checked, I see its in fact accurate and shows one of the best one day rises we have had for a while. Its just LSE's failure to print half the trades and their inability to keep chat rooms operational that's the problem!

Friday’s trades tell a very interesting story in my view. There were only 10 trades reported here, all bar one buys. Despite this very low volume, the price edged up on virtually every buy. Shares are clearly tightly held and in short supply. Fridays sp increase will be dwarfed by the increase we will see on any decent buying pressure, triggered either by news, technical indicators, or just plain old FOMO. All just my opinion, not advice. GLA.

Oh, and I don’t for a minute think that all of the benefit from CropX and Zero’s expansion is baked into the £1.57m pa Saas and they have not finished expanding yet, not by a long way. Nor are they the only ones.

Last year’s loss was actually $1.019m but we were also EBITA positive ( $300k) for the first time. Revenues bound to be knocked in a pandemic no, unless you are selling tests, masks etc. Yes we have been waiting for a catalyst for three years (longer in my case) but the price then was 2.5p and it’s now .8p We are much further forward than we were (and would have grown EBITA if it were not for the pandemic) so it’s much more of a bargain today than three years ago. It’s simple. If you believe in the company, buy or hold. If not sell. Of course you could try to trade it, but then, if I wanted to do that I would just keep quiet and get on with it.

Although obviously other factors may be affecting the sentiment/price action too.

Cheers Rich - definitely no intention to offend or call you a ‘chartist’. Actually, I found the chart quite helpful and I agree with your conclusion about what may be happening to prompt the rise.

Rich, I am not a technical analysis expert but I do get what you are saying. What strikes me though is that often you can draw lines in all sorts of ways to show different things. So, you can see the logic of the channel you draw, but what would technical analysis say about the higher lows we are seeing on that chart? Could an alternative channel show a long term uptrend, rather than a short term rise in a longer downtrend as implied by the channel you show?

Great update and very positive/confident. Very happy with my investment here.

Market cap about £3m. Last years revenues $6.8m. Saas recurring revenues alone recently confirmed as running at about £1.57m pa. Major customers such as Zero and Cropex doing well. Bank facility in place. Good management. We just need a catalyst to spark some buying volume and this will move up rapidly in my opinion but please do your research.